- Harrow ( NASDAQ: HROW ) said Wednesday it sold its non?ophthalmic compounding business to Innovation Compounding Pharmacy, an affiliate of Revelation Pharma.
- Terms were not disclosed.
- The sale includes formulations, customer accounts and other related assets.
- The deal did not involve a pharmaceutical production or dispensing facility.
- HROW will support Revelation during a three-month transition period, and Revelation will offer employment to HROW employees in the acquired business.
For further details see:
Harrow sells non?ophthalmic compounding business, terms undisclosed